Results 1 to 10 of about 20,714 (241)

Enzyme replacement therapy for pancreatic insufficiency: present and future

Clinical and Experimental Gastroenterology, 2011
Aaron Fieker1, Jessica Philpott1, Martine Armand21Division of Digestive Diseases, University of Oklahoma, OKC, OK, USA; 2INSERM, U476 "Nutrition Humaine et Lipides", Marseille, F-13385 France; Univ Méditerranée Aix-
Fieker A, Philpott J, Arm, M
doaj   +11 more sources

Pancreatic Enzyme Replacement Therapy in Pancreatic Cancer. [PDF]

Cancers (Basel), 2020
Pancreatic cancer is an aggressive malignancy and the seventh leading cause of global cancer deaths in industrialised countries. More than 80% of patients suffer from significant weight loss at diagnosis and over time tend to develop severe cachexia. A major cause of weight loss is malnutrition. Patients may experience pancreatic exocrine insufficiency
Pezzilli R, Caccialanza R, Capurso G, Brunetti O, Milella M, Falconi M.   +5 more
europepmc   +5 more sources

The effectiveness of pancreatic enzyme replacement therapy for malabsorption in advanced pancreatic cancer, a pilot study [PDF]

Palliative Care, 2019
Advanced adenocarcinoma of the pancreas has a globally poor prognosis. One of the characteristic features of pancreatic cancer (PC) is pancreatic exocrine insufficiency (PEI).
Amanda Landers, Helen Brown, Matthew Strother   +2 more
doaj   +3 more sources

Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma [PDF]

Frontiers in Oncology, 2021
BackgroundThe clinical consequences of pancreatic exocrine insufficiency and its treatment in advanced pancreatic ductal adenocarcinoma (PDAC) are poorly investigated.
Ilaria Trestini, Luisa Carbognin, Luisa Carbognin, Umberto Peretti, Isabella Sperduti, Alberto Caldart, Daniela Tregnago, Alice Avancini, Alessandra Auriemma, Giulia Orsi, Sara Pilotto, Luca Frulloni, Gabriele Capurso, Emilio Bria, Michele Reni, Giampaolo Tortora, Michele Milella   +16 more
doaj   +2 more sources

Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency [PDF]

Microbial Cell Factories, 2020
Background Exocrine pancreatic insufficiency (EPI) is characterized by the loss of active pancreatic enzymes and a resulting severely reduced food digestion. EPI therapy requires orally applied pancreatic enzyme replacement. The gut microbiome is a known
Sabrina Ritz, Daniela Hahn, Haleluya T. Wami, Karin Tegelkamp, Ulrich Dobrindt, Juergen Schnekenburger   +5 more
doaj   +2 more sources

Pancreatic enzyme replacement therapy can improve infection level nutrition condition and prognosis of patients with sepsis [PDF]

Food & Nutrition Research
Objective: This study aimed to investigate the effects of pancreatic enzyme replacement therapy (PERT) on infection level, nutrition condition and prognosis of patients with sepsis.
Li Zhao, Sheng Wang
doaj   +2 more sources

Pancreatic enzyme replacement therapy in subjects with exocrine pancreatic insufficiency and diabetes mellitus: a real-life, case–control study [PDF]

Diabetology & Metabolic Syndrome
Background Exocrine pancreatic insufficiency (EPI) can be associated with all types of diabetes. Pancreatic enzyme replacement therapy (PERT) has short and long-term benefits in subjects with EPI, but its effects on diabetes control are uncertain.
Laure Alexandre-Heymann, Fetta Yaker, Pierre Bel Lassen, Danièle Dubois-Laforgue, Etienne Larger   +4 more
doaj   +2 more sources

Survey of Pancreatic Enzyme Replacement Therapy Dosing Experiences in Adults with Exocrine Pancreatic Insufficiency. [PDF]

Healthcare (Basel), 2023
Lewis DM, Shahid A.
europepmc   +2 more sources

Hospitalization rates among patients with cystic fibrosis using pancreatic enzyme replacement therapy. [PDF]

Chron Respir Dis, 2020
Trapnell BC, Chen S, Khurmi R, Bodhani A, Kapoor M, Haupt M.   +5 more
europepmc   +2 more sources

Current and Future Therapeutic Approaches of Exocrine Pancreatic Insufficiency in Children with Cystic Fibrosis in the Era of Personalized Medicine

Pharmaceutics, 2023
This review presents current updates of pancreatic enzyme replacement therapy in children with cystic fibrosis based on literature published in the last decade and some special considerations regarding pancreatic enzyme replacement therapy in the era of ...
Mirela-Elena Ritivoiu, Cristina Manuela Drăgoi, Dumitru Matei, Iustina Violeta Stan, Alina Crenguţa Nicolae, Mihai Craiu, Ion-Bogdan Dumitrescu, Alina Angelica Ciolpan   +7 more
doaj   +1 more source